Literature DB >> 29290623

Identification of New Activators of Mitochondrial Fusion Reveals a Link between Mitochondrial Morphology and Pyrimidine Metabolism.

Laia Miret-Casals1, David Sebastián2, José Brea3, Eva M Rico-Leo4, Manuel Palacín5, Pedro M Fernández-Salguero4, M Isabel Loza3, Fernando Albericio6, Antonio Zorzano7.   

Abstract

Mitochondria are dynamic organelles that produce most of the cellular ATP, and are involved in many other cellular functions such as Ca2+ signaling, differentiation, apoptosis, cell cycle, and cell growth. One key process of mitochondrial dynamics is mitochondrial fusion, which is catalyzed by mitofusins (MFN1 and MFN2) and OPA1. The outer mitochondrial membrane protein MFN2 plays a relevant role in the maintenance of mitochondrial metabolism, insulin signaling, and mutations that cause neurodegenerative disorders. Therefore, modulation of proteins involved in mitochondrial dynamics has emerged as a potential pharmacological strategy. Here, we report the identification of small molecules by high-throughput screen that promote mitochondrial elongation in an MFN1/MFN2-dependent manner. Detailed analysis of their mode of action reveals a previously unknown connection between pyrimidine metabolism and mitochondrial dynamics. Our data indicate a link between pyrimidine biosynthesis and mitochondrial dynamics, which maintains cell survival under stress conditions characterized by loss of pyrimidine synthesis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  dihydroorotate dehydrogenase; leflunomide; mitochondrial morphology; phenotype screening; pyrimidine synthesis

Mesh:

Substances:

Year:  2017        PMID: 29290623     DOI: 10.1016/j.chembiol.2017.12.001

Source DB:  PubMed          Journal:  Cell Chem Biol        ISSN: 2451-9448            Impact factor:   8.116


  26 in total

Review 1.  Mitochondrial dynamics and their potential as a therapeutic target.

Authors:  B N Whitley; E A Engelhart; S Hoppins
Journal:  Mitochondrion       Date:  2019-06-19       Impact factor: 4.160

Review 2.  The Mitochondrion as an Emerging Therapeutic Target in Cancer.

Authors:  Katherine G Roth; Isa Mambetsariev; Prakash Kulkarni; Ravi Salgia
Journal:  Trends Mol Med       Date:  2019-07-18       Impact factor: 11.951

3.  Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer.

Authors:  Meifang Yu; Nicholas D Nguyen; Yanqing Huang; Daniel Lin; Tara N Fujimoto; Jessica M Molkentine; Amit Deorukhkar; Ya'an Kang; F Anthony San Lucas; Conrad J Fernandes; Eugene J Koay; Sonal Gupta; Haoqiang Ying; Albert C Koong; Joseph M Herman; Jason B Fleming; Anirban Maitra; Cullen M Taniguchi
Journal:  JCI Insight       Date:  2019-07-23

4.  Pharmacophore-Based Design of Phenyl-[hydroxycyclohexyl] Cycloalkyl-Carboxamide Mitofusin Activators with Improved Neuronal Activity.

Authors:  Xiawei Dang; Sidney B Williams; Sriram Devanathan; Antonietta Franco; Lijun Fu; Peter R Bernstein; Daniel Walters; Gerald W Dorn
Journal:  J Med Chem       Date:  2021-08-20       Impact factor: 7.446

5.  Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer.

Authors:  Brock A Humphries; Alyssa C Cutter; Johanna M Buschhaus; Yu-Chih Chen; Tonela Qyli; Dilrukshika S W Palagama; Samantha Eckley; Tanner H Robison; Avinash Bevoor; Benjamin Chiang; Henry R Haley; Saswat Sahoo; Phillip C Spinosa; Dylan B Neale; Jagadish Boppisetti; Debashis Sahoo; Pradipta Ghosh; Joerg Lahann; Brian D Ross; Eusik Yoon; Kathryn E Luker; Gary D Luker
Journal:  Breast Cancer Res       Date:  2020-06-05       Impact factor: 6.466

Review 6.  Mitochondrial function in development and disease.

Authors:  Marlies P Rossmann; Sonia M Dubois; Suneet Agarwal; Leonard I Zon
Journal:  Dis Model Mech       Date:  2021-06-11       Impact factor: 5.758

7.  The dysregulated Pink1- Drosophila mitochondrial proteome is partially corrected with exercise.

Authors:  Brad Ebanks; Thomas L Ingram; Gunjan Katyal; John R Ingram; Nicoleta Moisoi; Lisa Chakrabarti
Journal:  Aging (Albany NY)       Date:  2021-06-01       Impact factor: 5.682

Review 8.  Hypothalamic Mitochondrial Dysfunction as a Target in Obesity and Metabolic Disease.

Authors:  Juan Cunarro; Sabela Casado; Javier Lugilde; Sulay Tovar
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-31       Impact factor: 5.555

Review 9.  Mitochondrial targeting as a novel therapy for stroke.

Authors:  Eleonora Russo; Hung Nguyen; Trenton Lippert; Julian Tuazon; Cesar V Borlongan; Eleonora Napoli
Journal:  Brain Circ       Date:  2018-10-09

Review 10.  Understanding the Role of Dysfunctional and Healthy Mitochondria in Stroke Pathology and Its Treatment.

Authors:  Hung Nguyen; Sydney Zarriello; Mira Rajani; Julian Tuazon; Eleonora Napoli; Cesar V Borlongan
Journal:  Int J Mol Sci       Date:  2018-07-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.